These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1902671)

  • 21. Sepiapterin reductase and ALR2 ("aldose reductase") from bovine brain.
    Dowling TG; O'Rourke JF; Tipton KF
    Adv Exp Med Biol; 1993; 328():313-24. PubMed ID: 8493908
    [No Abstract]   [Full Text] [Related]  

  • 22. ISOLATION AND PROPERTIES OF LENS ALDOSE REDUCTASE.
    HAYMAN S; KINOSHITA JH
    J Biol Chem; 1965 Feb; 240():877-82. PubMed ID: 14275148
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of sorbitol metabolism in renal inner medulla of diabetic rats: regulation by substrate, cosubstrate and products of the aldose reductase reaction.
    Grunewald RW; Weber II; Kinne-Saffran E; Kinne RK
    Biochim Biophys Acta; 1993 Nov; 1225(1):39-47. PubMed ID: 8241288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatographic separation of activated and unactivated forms of aldose reductase.
    Grimshaw CE
    Arch Biochem Biophys; 1990 Apr; 278(1):273-6. PubMed ID: 2108605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of the nicotinamide adenine dinucleotide phosphate-dependent aldehyde reductase from pig kidney. Amino acid composition, reactivity of cysteinyl residues, and stereochemistry of D-glyceraldehyde reduction.
    Flynn TG; Shires J; Walton DJ
    J Biol Chem; 1975 Apr; 250(8):2933-40. PubMed ID: 235531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regulation of aldose reductase activity. The influence of effectors on reverse isomerization of the enzyme].
    Pavlov AR; Vartanov SS; Iaropolov AI
    Biokhimiia; 1991 Nov; 56(11):1999-2015. PubMed ID: 1805983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of the NAD(P)H-dependent xylose reductase from the xylose-fermenting yeast Pichia stipitis.
    Verduyn C; Van Kleef R; Frank J; Schreuder H; Van Dijken JP; Scheffers WA
    Biochem J; 1985 Mar; 226(3):669-77. PubMed ID: 3921014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regulation of crystalline lens aldose reductase activity. Nonhyperbolic oxidation kinetics of NADPH by glucose].
    Vartanov SS; Pavlov AR; Iaropolov AI
    Biokhimiia; 1990 Nov; 55(11):2046-57. PubMed ID: 2128191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAD(P)H-dependent aldose reductase from the xylose-assimilating yeast Candida tenuis. Isolation, characterization and biochemical properties of the enzyme.
    Neuhauser W; Haltrich D; Kulbe KD; Nidetzky B
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):683-92. PubMed ID: 9307017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of aldose reductase and aldehyde reductase from human kidney.
    Ansari NH; Bhatnagar A; Liu SQ; Srivastava SK
    Biochem Int; 1991 Nov; 25(4):755-65. PubMed ID: 1815509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active site modification of aldose reductase by nitric oxide donors.
    Chandra A; Srivastava S; Petrash JM; Bhatnagar A; Srivastava SK
    Biochim Biophys Acta; 1997 Sep; 1341(2):217-22. PubMed ID: 9357961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A reaction mechanism for aldose reductase from lens.
    Doughty CC; Conrad SM
    Biochim Biophys Acta; 1982 Nov; 708(3):358-64. PubMed ID: 6816290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A kinetic perspective on the peculiarity of aldose reductase.
    Grimshaw CE
    Adv Exp Med Biol; 1991; 284():217-28. PubMed ID: 1905101
    [No Abstract]   [Full Text] [Related]  

  • 35. Modification of aldose reductase by S-nitrosoglutathione.
    Chandra A; Srivastava S; Petrash JM; Bhatnagar A; Srivastava SK
    Biochemistry; 1997 Dec; 36(50):15801-9. PubMed ID: 9398310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate.
    Vander Jagt DL; Kolb NS; Vander Jagt TJ; Chino J; Martinez FJ; Hunsaker LA; Royer RE
    Biochim Biophys Acta; 1995 Jun; 1249(2):117-26. PubMed ID: 7599164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectroscopic properties of Escherichia coli UDP-N-acetylenolpyruvylglucosamine reductase.
    Axley MJ; Fairman R; Yanchunas J; Villafranca JJ; Robertson JG
    Biochemistry; 1997 Jan; 36(4):812-22. PubMed ID: 9020779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
    Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
    Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding energy and specificity in the catalytic mechanism of yeast aldose reductases.
    Nidetzky B; Mayr P; Hadwiger P; Stütz AE
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):101-7. PubMed ID: 10548539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of aldose reductase from human tissues.
    Das B; Srivastava SK
    Diabetes; 1985 Nov; 34(11):1145-51. PubMed ID: 3930326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.